MetLife, Inc. (NYSE:MET)‘s stock had its “buy” rating reiterated by Langen Mcalenn in a research report issued on Wednesday.

A number of other analysts also recently issued reports on the company. BidaskClub raised MetLife from a “sell” rating to a “hold” rating in a research note on Wednesday, August 9th. Zacks Investment Research downgraded MetLife from a “hold” rating to a “sell” rating in a research report on Wednesday, August 9th. Wells Fargo & Company reissued a “buy” rating on shares of MetLife in a research report on Saturday, July 1st. ValuEngine raised MetLife from a “buy” rating to a “strong-buy” rating in a research report on Friday, August 11th. Finally, TheStreet raised MetLife from a “c” rating to a “b-” rating in a research report on Monday, July 24th. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $59.17.

Shares of MetLife (NYSE:MET) opened at 47.95 on Wednesday. The firm’s 50-day moving average is $49.04 and its 200 day moving average is $51.56. MetLife has a 12-month low of $40.07 and a 12-month high of $58.09. The stock has a market capitalization of $50.96 billion, a P/E ratio of 564.12 and a beta of 1.46.

MetLife (NYSE:MET) last posted its quarterly earnings data on Wednesday, August 2nd. The financial services provider reported $1.30 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.28 by $0.02. MetLife had a return on equity of 8.51% and a net margin of 0.30%. The firm had revenue of $17.39 billion for the quarter, compared to analysts’ expectations of $17.11 billion. During the same period in the previous year, the firm earned $0.83 EPS. The business’s quarterly revenue was up 2.5% on a year-over-year basis. On average, equities research analysts forecast that MetLife will post $4.88 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This piece of content was first published by American Banking News and is the property of of American Banking News. If you are viewing this piece of content on another site, it was copied illegally and reposted in violation of US and international copyright laws. The legal version of this piece of content can be read at https://www.americanbankingnews.com/2017/08/17/metlife-inc-met-earns-buy-rating-from-langen-mcalenn.html.

Institutional investors have recently added to or reduced their stakes in the company. Gofen & Glossberg LLC IL boosted its stake in MetLife by 1.5% in the second quarter. Gofen & Glossberg LLC IL now owns 385,527 shares of the financial services provider’s stock worth $21,181,000 after buying an additional 5,515 shares in the last quarter. Schafer Cullen Capital Management Inc. raised its stake in MetLife by 6.3% in the second quarter. Schafer Cullen Capital Management Inc. now owns 2,212,401 shares of the financial services provider’s stock worth $121,549,000 after buying an additional 132,050 shares during the last quarter. Cullen Capital Management LLC raised its stake in MetLife by 3.0% in the second quarter. Cullen Capital Management LLC now owns 1,414,720 shares of the financial services provider’s stock worth $77,725,000 after buying an additional 41,280 shares during the last quarter. First Fiduciary Investment Counsel Inc. raised its stake in MetLife by 4.4% in the second quarter. First Fiduciary Investment Counsel Inc. now owns 302,710 shares of the financial services provider’s stock worth $16,631,000 after buying an additional 12,834 shares during the last quarter. Finally, Krilogy Financial LLC raised its stake in MetLife by 154.7% in the second quarter. Krilogy Financial LLC now owns 3,555 shares of the financial services provider’s stock worth $195,000 after buying an additional 2,159 shares during the last quarter. Institutional investors own 75.61% of the company’s stock.

About MetLife

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings; Brighthouse Financial, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Analyst Recommendations for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related companies with MarketBeat.com's FREE daily email newsletter.